Molecular mechanisms and clinical implications of reversible protein S-glutathionylation

Antioxidants and Redox Signaling

Volumn 10, Issue 11, 2008, Pages 1941-1988

  Mieyal, John J ^a,b   Gallogly, Molly M ^a   Qanungo, Suparna ^a   Sabens, Elizabeth A ^a,b   Shelton, Melissa D ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALDEHYDE REDUCTASE; FLAVOPROTEIN SULFHYDRYL OXIDASE; GLUCOSE; GLUTAREDOXIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN C JUN; PROTEIN KINASE B; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SULFENIC ACID DERIVATIVE; SULFONIC ACID DERIVATIVE; THIOL OXIDASE; THIOPHENE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

AMINO ACID SEQUENCE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CATALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; EXOCYTOSIS; GLUCOSE METABOLISM; GLUTATHIONYLATION; GRANULOMATOSIS; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INTRACELLULAR SPACE; ISCHEMIC PRECONDITIONING; LUNG INJURY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GLUTATHIONE; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 51349088530     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2089     Document Type: Review

References (352)

1. Adachi T, Pimentel DR, Heibeck T, Hou X, Lee YJ, Jiang B, Ido Y, and Cohen RA. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem 279: 29857-29862, 2004.
2. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, and Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10: 1200-1207, 2004.
3. Aguirre V, Uchida T, Yenush L, Davis R, and White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000.
4. Aksenov MY and Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 302: 141-145, 2001.
5. Akterin S, Cowburn RF, Miranda-Vizuete A, Jimenez A, Bogdanovic N, Winblad B, and Cedazo-Minguez A. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ 13: 1454-1465, 2006.
6. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10 Suppl: S18-S25, 2004.
7. Andjelkovic M, Jakubowicz T, Cron P, Ming XF, Han JW, and Hemmings BA. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci USA 93: 5699-5704, 1996.
8. Applegate MA, Humphries KM, and Szweda LI. Reversible inhibition of alpha-ketoglutarate dehydrogenase by hydrogen peroxide: glutathionylation and protection of lipoic acid. Biochemistry 47: 473-478, 2008.
9. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, and Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 95: 7659-7663, 1998.
10. Aracena P, Sanchez G, Donoso P, Hamilton SL, and Hidalgo C. S-glutathionylation decreases Mg2+ inhibition and S-nitrosylation enhances Ca2+ activation of RyR1 channels. J Biol Chem 278: 42927-42935, 2003.
11. Aracena-Parks P, Goonasekera SA, Gilman CP, Dirksen RT, Hidalgo C, and Hamilton SL. Identification of cysteines involved in S-nitrosylation, S-glutathionyxlation, and oxidation to disulfides in ryanodine receptor type 1. J Biol Chem 281: 40354-40368, 2006.
12. Arai T, Nakamura M, Magori E, Fukuda M, and Sako T. Decrease in malate dehydrogenase activities in peripheral leucocytes of type 1 diabetic dogs. Res Vet Sci 74: 183-185, 2003.
13. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198, 2005.
14. Arnelle DR and Stamler JS. NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318: 279-285, 1995.
15. Arredouani A, Guiot Y, Jonas JC, Liu LH, Nenquin M, Pertusa JA, Rahier J, Rolland JF, Shull GE, Stevens M, Wuytack F, Henquin JC, and Gilon P. SERCA3 ablation does not impair insulin secretion but suggests distinct roles of different sarcoendoplasmic reticulum Ca(2+) pumps for Ca(2+) homeostasis in pancreatic beta-cells. Diabetes 51: 3245-3253, 2002.
16. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115: 2047-2058, 2005.
17. Askelof P, Axelsson K, Eriksson S and Mannervik B. Mechanism of action of enzymes catalyzing thiol-disulfide interchange. Thioltransferases rather than transhydrogenases. FEBS Lett 38: 263-267, 1974.
18. Ayene IS, Biaglow JE, Kachur AV, Stamato TD, and Koch CJ. Mutation in G6PD gene leads to loss of cellular control of protein glutathionylation: mechanism and implication. J Cell Biochem 103: 123-135, 2008.
19. Bandyopadhyay S, Starke DW, Mieyal JJ, and Gronostajski RM. Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of oxidation-inactivated nuclear factor I. J Biol Chem 273: 392-397, 1998.
20. Barrett WC, DeGnore JP, Keng YF, Zhang ZY, Yim MB, and Chock PB. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J Biol Chem 274: 34543-34546, 1999.
21. Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB, and Chock PB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38: 6699-6705, 1999.
22. Barthel A and Klotz LO. Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress. Biol Chem 386: 207-216, 2005.
23. Beauvois MC, Merezak C, Jonas JC, Ravier MA, Henquin JC, and Gilon P. Glucose-induced mixed [Ca2+]c oscillations in mouse beta-cells are controlled by the membrane potential and the SERCA3 Ca2+-ATPase of the endoplasmic reticulum. Am J Physiol Cell Physiol 290: C1503-C1511, 2006.
24. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, and Murphy MP. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 279: 47939-47951, 2004.
25. Berndt C, Hudemann C, Hanschmann EM, Axelsson R, Holmgren A, and Lillig CH. How does iron-sulfur cluster coordination regulate the activity of human glutaredoxin 2? Antioxid Redox Signal 9: 151-157, 2007.
26. Biaglow JE, Donahue J, Tuttle S, Held K, Chrestensen C, and Mieyal J. A method for measuring disulfide reduction by cultured mammalian cells: relative contributions of glutathione-dependent and glutathione-independent mechanisms. Anal Biochem 281: 77-86, 2000.
27. Bidasee KR, Dincer UD, and Besch HR, Jr. Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats. Mol Pharmacol 60: 1356-1364, 2001.
28. Biswas S, Chida AS, and Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 71: 551-564, 2006.
29. Borges CR, Geddes T, Watson JT, and Kuhn DM. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J Biol Chem 277: 48295-48302, 2002.
30. Bredesen DE, Rao RV, and Mehlen P. Cell death in the nervous system. Nature 443: 796-802, 2006.
31. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
32. Buetler TM, Gallagher EP, Wang C, Stahl DL, Hayes JD, and Eaton DL. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol 135: 45-57, 1995.
33. Burwell LS, Nadtochiy SM, Tompkins AJ, Young S, and Brookes PS. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 394: 627-634, 2006.
34. Cabiscol E and Levine RL. The phosphatase activity of carbonic anhydrase III is reversibly regulated by glutathiolation. Proc Natl Acad Sci USA 93: 4170-4174, 1996.
35. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, and Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11: 183-190, 2005.
36. Cantin AM, White TB, Cross CE, Forman HJ, Sokol RJ, and Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003. Free Radic Biol Med 42: 15-31, 2007.
37. Cenini G, Sultana R, Memo M, and Butterfield DA. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radic Biol Med 45: 81-85, 2008.
38. Chandra A, Srivastava S, Petrash JM, Bhatnagar A, and Srivastava SK. Modification of aldose reductase by S-nitrosoglutathione. Biochemistry 36: 15801-15809, 1997.
39. Chen FC and Ogut O. Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin. Am J Physiol Cell Physiol 290: C719-C727, 2006.
40. Cheu HS, Shan YX, Yang TL, Lin HD, Chen JW, Lin SJ, and Wang PH. Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 54: 175-181, 2005.
41. Chen YR, Chen CL, Pfeiffer DR, and Zweier JL. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J Biol Chem 282: 32640-32654, 2007.
42. Cheng HP, Wei S, Wei LP, and Verkhratsky A. Calcium signaling in physiology and pathophysiology. Acta Pharmacol Sin 27: 767-772, 2006.
43. Chrestensen CA, Starke DW, and Mieyal JJ. Acute cadmium exposure inactivates thioltransferase (Glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis. J Biol Chem 275: 26556-26565, 2000.
44. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, and Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233, 2008.
45. Chu F, Ward NE, and O'Brian CA. Potent inactivation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumor-promotion/progression antagonist glutathione but not by its precursor cysteine. Carcinogenesis 22: 1221-1229, 2001.
46. Chu F, Ward NE, and O'Brian CA. PKC isozyme S-cysteinylation by cystine stimulates the pro-apoptotic isozyme PKC delta and inactivates the oncogenic isozyme PKC epsilon. Carcinogenesis 24: 317-325, 2003.
47. Claiborne A, Miller H, Parsonage D, and Ross RP. Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation. FASEB J 7: 1483-1490, 1993.
48. Clarke M and Dodson PM. PKC inhibition and diabetic microvascular complications. Best Pract Res Clin Endocrinol Metab 21: 573-586, 2007.
49. Clavreul N, Adachi T, Pimental DR, Ido Y, Schoneich C, and Cohen RA. S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J 20: 518-520, 2006.
50. Clavreul N, Bachschmid MM, Hou X, Shi C, Idrizovic A, Ido Y, Pimentel D, and Cohen RA. S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 26: 2454-2461, 2006.
51. Clegg HV, Itahana K, and Zhang Y. Unlocking the Mdm2-p53 loop: Ubiquitin is the key. Cell Cycle 7: 287-292, 2008.
52. Coetzee WA, Nakamura TY, and Faivre JF. Effects of thiol-modifying agents on KATP channels in guinea pig ventricular cells. Am J Physiol 269: H1625-H1633, 1995.
53. Colell A, Ricci JE, Tait S, Milasta S, Maurer U, Bouchier-Hayes L, Fitzgerald P, Guio-Carrion A, Waterhouse NJ, Li CW, Mari B, Barbry P, Newmeyer DD, Beere HM, and Green DR. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 129: 983-997, 2007.
54. Coppock DL and Thorpe C. Multidomain flavin-dependent sulfhydryl oxidases. Antioxid Redox Signal 8: 300-311, 2006.
55. Cotgreave IA and Gerdes RG. Recent trends in glutathione biochemistry-glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem Biophys Res Commun 242: 1-9, 1998.
56. Coughlan MT, Cooper ME, and Forbes JM. Renal microvascular injury in diabetes: RAGE and redox signaling. Antioxid Redox Signal 9: 331-342, 2007.
57. Crabb DW. The effect of experimental diabetes on liver alcohol dehydrogenase activity in rats. Alcohol Clin Exp Res 10: 77-80, 1986.
58. Cross JV and Templeton DJ. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J 381: 675-683, 2004.
59. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, and Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282: 2871-2879, 2007.
60. Dafre AL, Sies H, and Akerboom T. Protein S-thiolation and regulation of microsomal glutathione transferase activity by the glutathione redox couple. Arch Biochem Biophys 332: 288-294, 1996.
61. Dai Y, Wei Z, Sephton CF, Zhang D, Anderson DH, and Mousseau DD. Haloperidol induces the nuclear translocation of phosphatidylinositol 3′-kinase to disrupt Akt phosphorylation in PC12 cells. J Psychiatry Neurosci 32: 323-330, 2007.
62. Dalle-Donne I, Giustarini D, Rossi R, Colombo R, and Milzani A. Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med 34: 23-32, 2003.
63. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, and Rossi R. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 10: 445-473, 2008.
64. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, and Milzani A. Actin S-glutathionylation: evidence against a thiol-disulphide exchange mechanism. Free Radic Biol Med 35: 1185-1193, 2003.
65. Das DK. Thioredoxin regulation of ischemic preconditioning. Antioxid Redox Signal 6: 405-412, 2004.
66. Das R, Ponnappan S, and Ponnappan U. Redox regulation of the proteasome in T lymphocytes during aging. Free Radic Biol Med 42: 541-551, 2007.
67. Davis DA, Dorsey K, Wingfield PT, Stahl SJ, Kaufman J, Fales HM, and Levine RL. Regulation of HIV-1 protease activity through cysteine modification. Biochemistry 35: 2482-2488, 1996.
68. Davis DA, Newcomb FM, Starke DW, Ott DE, Mieyal JJ, and Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J Biol Chem 272: 25935-25940, 1997.
69. Demasi M, Silva GM, and Netto LE. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J Biol Chem 278: 679-685, 2003.
70. Di Noto L. Biochemical Investigation of Tau and MAP2: polymerization implications for neuropathic filament assembly in Alzheimer's disease (Dissertation). University of Florida, Gainsville, FL, 2002.
71. Di Noto L, Deture MA, and Purich DL. Disulfide-crosslinked tau and MAP2 homodimers readily promote microtubule assembly. Mol Cell Biol Res Commun 2: 71-76, 1999.
72. Di Noto L, Deture MA, and Purich DL. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein. Microsc Res Tech 67: 156-163, 2005.
73. Di Simplicio P, de Giorgio LA, Cardaioli E, Lecis R, Miceli M, Rossi R, Anichini R, Mian M, Seghieri G, and Franconi F. Glutathione, glutathione utilizing enzymes and thioltransferase in platelets of insulin-dependent diabetic patients: relation with platelet aggregation and with microangiopatic complications. Eur J Clin Invest 25: 665-669, 1995.
74. Di Simplicio P, Jensson H, and Mannervik B. Effects of inducers of drug metabolism on basic hepatic forms of mouse glutathione transferase. Biochem J 263: 679-685, 1989.
75. Diwakar L, Kenchappa RS, Annepu J, and Ravindranath V. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity. Neurochem Int 51: 37-46, 2007.
76. Dixon WG and Symmons DP. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. Ann Rheum Dis 66: 1132-1136, 2007.
77. Domenech RJ, Macho P, Velez D, Sanchez G, Liu X, and Dhalla N. Tachycardia preconditions infarct size in dogs: role of adenosine and protein kinase C. Circulation 97: 786-794, 1998.
78. Downey JM, Davis AM, and Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev 12: 181-188, 2007.
79. Dror V, Kalynyak TB, Bychkivska Y, Frey MH, Tee M, Jeffrey KD, Nguyen V, Luciani DS, and Johnson JD. Glucose and ER-calcium channels regulate HIF-1beta via presenilin in pancreatic beta cells. J Biol Chem 283: 9909-9916, 2008.
80. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, and Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112: 1049-1057, 2003.
81. Du ZX, Wang HQ, Zhang HY, and Gao DX. Involvement of glyceraldehyde-3- phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 148: 4352-4361, 2007.
82. Eaton P, Wright N, Hearse DJ, and Shattock MJ. Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion. J Mol Cell Cardiol 34: 1549-1560, 2002.
83. Eaton P and Shattock MJ. Purification of proteins susceptible to oxidation at cysteine residues: identification of malate dehydrogenase as a target for S-glutathiolation. Ann NY Acad Sci 973: 529-532, 2002.
84. Efrat S, Fleischer N, and Hanahan D. Diabetes induced in male transgenic mice by expression of human H-ras oncoprotein in pancreatic beta cells. Mol Cell Biol 10: 1779-1783, 1990.
85. Ehrhart J, Gluck M, Mieyal J, and Zeevalk GD. Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism Relat Disord 8: 395-400, 2002.
86. Eiserich JP, Patel RP, and O'Donnell VB. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 19: 221-357, 1998.
87. Ejima K, Nanri H, Araki M, Uchida K, Kashimura M, and Ikeda M. 17beta-estradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress. Eur J Endocrinol 140: 608-613, 1999.
88. England K and Cotter TG. Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis. Redox Rep 10: 237-245, 2005.
89. Enoksson M, Fernandes AP, Prast S, Lillig CH, Holmgren A, and Orrenius S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun 327: 774-779, 2005.
90. Erkasap N. SERCA in genesis of arrhythmias: what we already know and what is new? Anadolu Kardiyol Derg 7 Suppl 1: 43-46, 2007.
91. Fernando MR, Lechner JM, Lofgren S, Gladyshev VN, and Lou MF. Mitochondrial thioltransferase (glutaredoxin 2) has GSH-dependent and thioredoxin reductase-dependent peroxidase activities in vitro and in lens epithelial cells. FASEB J 20: 2645-2647, 2006.
92. Findlay VJ, Townsend DM, Morris TE, Fraser JP, He L, and Tew KD. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res 66: 6800-6806, 2006.
93. Fine RL, Patel J, and Chabner BA. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85: 582-586, 1988.
94. Flohe L. The glutathione peroxidase reaction: molecular basis of the antioxidant function of selenium in mammals. Curr Top Cell Regul 27: 473-478, 1985.
95. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, Bonetto V, Mengozzi M, Duffieux F, Miclet E, Bachi A, Vandekerckhove J, Gianazza E, and Ghezzi P. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci USA 99: 3505-3510, 2002.
96. Freeman BA and Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 256: 10986-10992, 1981.
97. Friling RS, Bergelson S, and Daniel V. Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene. Proc Natl Acad Sci USA 89: 668-672, 1992.
98. Gallogly MM and Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7: 381-391, 2007.
99. Gallogly MM, Starke DW, Leonberg AK, Ospina SE, and Mieyal JJ. Kinetic and mechanistic characterization, and versatile catalytic properties of mammalian glutaredoxin 2 (Grx 2): implications for intracellular roles. Biochemistry in press, 2008.
100. Gama V, Yoshida T, Gomez JA, Basile DP, Mayo LD, Haas AL, and Matsuyama S. Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis. Exp Cell Res 312: 488-499, 2006.
101. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, and Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277: 48115-48121, 2002.
102. Garden GA and Morrison RS. The multiple roles of p53 in the pathogenesis of HIV associated dementia. Biochem Biophys Res Commun 331: 799-809, 2005.
103. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta 1411: 323-333, 1999.
104. Gilbert HF. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol Relat Areas Mol Biol 63: 69-172, 1990.
105. Gilbert HF. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol 251: 8-28, 1995.
106. Giles GI. The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des 12: 4427-4443, 2006.
107. Giustarini D, Milzani A, Aldini G, Carini M, Rossi R, and Dalle-Donne I. S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione. Antioxid Redox Signal 7: 930-939, 2005.
108. Gladyshev VN, Liu A, Novoselov SV, Krysan K, Sun QA, Kryukov VM, Kryukov GV, and Lou MF. Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J Biol Chem 276: 30374-30380, 2001.
109. Gnudi L, Frevert EU, Houseknecht KL, Erhardt P, and Kahn BB. Adenovirus-mediated gene transfer of dominant negative ras(asn17) in 3T3L1 adipocytes does not alter insulin-stimulated P13-kinase activity or glucose transport. Mol Endocrinol 11: 67-76, 1997.
110. Goldstein BJ. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Curr Drug Targets Immune Endocr Metabol Disord 1: 265-275, 2001.
111. Goldstein BJ, Mahadev K, and Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54: 311-321, 2005.
112. Grammatopoulos TN, Jones SM, Ahmadi FA, Hoover BR, Snell LD, Skoch J, Jhaveri VV, Poczobutt AM, Weyhenmeyer JA, and Zawada WM. Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. Mol Neurodegener 2: 1, 2007.
113. Grammatopoulos TN, Outeiro TF, Hyman BT, and Standaert DG. Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro. Biochem Biophys Res Commun 363: 846-851, 2007.
114. Grankvist K, Marklund S, Sehlin J, and Taljedal IB. Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro. Biochem J 182: 17-25, 1979.
115. Gravina SA and Mieyal JJ. Thioltransferase is a specific glutathionyl mixed disulfide oxidoreductase. Biochemistry 32: 3368-3376, 1993.
116. Gu Q, Bowden GT, Normolle D, and Sun Y. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB. J Cell Biol 178: 1009-1023, 2007.
117. Gupte A and Mumper RJ. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells. Free Radic Biol Med 43: 1271-1278, 2007.
118. Hackett NR, Heguy A, Harvey BG, O'Connor TP, Luettich K, Flieder DB, Kaplan R, and Crystal RG. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 29: 331-343, 2003.
119. Haluzik M, Anderlova K, Dolezalova R, Adamikova A, Haluzikova D, Housova J, Svacina S, and Haluzik M. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitut and obesity: the influence of fenofibrate treatment. Physiol Res 2008.
120. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, and Sawa A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7: 665-674, 2005.
121. Harrison D, Gongora MC, Guzik TJ, and Widder J. Oxidative Stress and Hypertension. J Am Soc Hypert 1: 30-44, 2007.
122. Hashemy SI, Johansson C, Berndt C, Lillig CH, and Holmgren A. Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity. J Biol Chem 282: 14428-14436, 2007.
123. Hausenloy DJ and Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70: 240-253, 2006.
124. Heineke J and Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600, 2006.
125. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49: 1751-1760, 2000.
126. Hie M, Shimono M, Fujii K, and Tsukamoto I. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone 41: 1045-1050, 2007.
127. Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, Itoh T, Fukuda K, and Yodoi J. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem Biophys Res Commun 274: 177-182, 2000.
128. Hirst J, Carroll J, Fearnley IM, Shannon RJ, and Walker JE. The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta 1604: 135-150, 2003.
129. Ho YS, Xiong Y, Ho DS, Gao J, Chua BH, Pai H, and Mieyal JJ. Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia. Free Radic Biol Med 43: 1299-1312, 2007.
130. Hogg N. The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 42: 585-600, 2002.
131. Holmgren A. Hydrogen donor system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc Natl Acad Sci USA 73: 2275-2279, 1976.
132. Huang KP and Huang FL. Glutathionylation of proteins by glutathione disulfide S-oxide. Biochem Pharmacol 64: 1049-1056, 2002.
133. Humphries KM, Juliano C, and Taylor SS. Regulation of cAMP-dependent protein kinase activity by glutathionylation. J Biol Chem 277: 43505-43511, 2002.
134. Hurd TR, Costa NJ, Dahm CC, Beer SM, Brown SE, Filipovska A, and Murphy MP. Glutathionylation of mitochondrial proteins. Antioxid Redox Signal 7: 999-1010, 2005.
135. Inoue T, Wu L, Stuart J, and Maki CG. Control of p53 nuclear accumulation in stressed cells. FEBS Lett 579: 4978-4984, 2005.
136. Ischiropoulos H and Beckman JS. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111: 163-169, 2003.
137. Ishitani R, Tajima H, Takata H, Tsuchiya K, Kuwae T, Yamada M, Takahashi H, Tatton NA, and Katsube N. Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs. Prog Neuropsychopharmacol Biol Psychiatry 27: 291-301, 2003.
138. Ivarsson R, Quintens R, Dejonghe S, Tsukamoto K, in't Veld P, Renstrom E, and Schuit FC. Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54: 2132-2142, 2005.
139. Jahngen-Hodge J, Obin MS, Gong X, Shang F, Nowell TR, Jr., Gong J, Abasi H, Blumberg J, and Taylor A. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 272: 28218-28226, 1997.
140. Jao SC, English Ospina SM, Berdis AJ, Starke DW, Post CB, and Mieyal JJ. Computational and mutational analysis of human glutaredoxin (thioltransferase): probing the molecular basis of the low pKa of cysteine 22 and its role in catalysis. Biochemistry 45: 4785-4796, 2006.
141. Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, Liu RM, Forman HJ, and Andersen JK. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J Biol Chem 275: 26096-26101, 2000.
142. Jha N, Kumar MJ, Boonplueang R, and Andersen JK. Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease? J Neurochem 80: 555-561, 2002.
143. Ji Y, Akerboom TP, Sies H, and Thomas JA. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys 362: 67-78, 1999.
144. Johansson C, Kavanagh KL, Gileadi O, and Oppermann U. Reversible sequestration of active site cysteines in a 2Fe-2S-bridged dimer provides a mechanism for glutaredoxin 2 regulation in human mitochondria. J Biol Chem 282: 3077-3082, 2007.
145. Johansson C, Lillig CH, and Holmgren A. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem 279: 7537-7543, 2004.
146. Johnson JD, Kuang S, Misler S, and Polonsky KS. Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. FASEB J 18: 878-880, 2004.
147. Jones WK, Brown M, Ren X, He S, and McGuinness M. NFkappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol 3: 229-254, 2003.
148. Jourd'heuil D, Jourd'heuil FL, and Feelisch M. Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. Evidence for a free radical mechanism. J Biol Chem 278: 15720-15726, 2003.
149. Jung CH and Thomas JA. S-glutathiolated hepatocyte proteins and insulin disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein disulfide isomerase, and glutathione. Arch Biochem Biophys 335: 61-72, 1996.
150. Kamata H, Honda S, Maeda S, Chang L, Hirata H, and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661, 2005.
151. Kanda M, Ihara Y, Murata H, Urata Y, Kono T, Yodoi J, Seto S, Yano K, and Kondo T. Glutaredoxin modulates platelet-derived growth factor-dependent cell signaling by regulating the redox status of low molecular weight protein-tyrosine phosphatase. J Biol Chem 281: 28518-28528, 2006.
152. Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, and Yamasaki Y. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal 9: 355-366, 2007.
153. Karin M and Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002.
154. Karoui H, Hogg N, Frejaville C, Tordo P, and Kalyanaraman B. Characterization of sulfur-centered radical intermediates formed during the oxidation of thiols and sulfite by peroxynitrite. ESR-spin trapping and oxygen uptake studies. J Biol Chem 271: 6000-6009, 1996.
155. Karunakaran S, Diwakar L, Saeed U, Agarwal V, Ramakrishnan S, Iyengar S, and Ravindranath V. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. FASEB J 21: 2226-2236, 2007.
156. Karunakaran S, Saeed U, Ramakrishnan S, Koumar RC, and Ravindranath V. Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain. Brain Res 1185: 8-17, 2007.
157. Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, Sorrentino V, and O'Neill C. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies. Neuroscience 92: 499-513, 1999.
158. Kenchappa RS, Diwakar L, Boyd MR, and Ravindranath V. Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury. J Neurosci 22: 8402-8410, 2002.
159. Kenchappa RS and Ravindranath V. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: studies with MPTP. FASEB J 17: 717-719, 2003.
160. Kher N and Marsh JD. Pathobiology of atherosclerosis - a brief review. Semin Thromb Hemost 30: 665-672, 2004.
161. Kil IS and Park JW. Regulation of mitochondrial NADP+-dependent isocitrate dehydrogenase activity by glutathionylation. J Biol Chem 280: 10846-10854, 2005.
162. Kim H. DNA repair Ku proteins in gastric cancer cells and pancreatic acinar cells. Amino Acids 34: 195-202, 2008.
163. King GL, Shiba T, Oliver J, Inoguchi T, and Bursell SE. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 45: 179-188, 1994.
164. Klatt P and Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 267: 4928-4944, 2000.
165. Klatt P, Molina EP, De Lacoba MG, Padilla CA, Martinez-Galesteo E, Barcena JA, and Lamas S. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J 13: 1481-1490, 1999.
166. Klatt P, Molina EP, and Lamas S. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J Biol Chem 274: 15857-15864, 1999.
167. Kowluru V and Kowluru RA. Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina. Mol Vis 13: 602-610, 2007.
168. Koya D and King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
169. Kumar S and Holmgren A. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters. Carcinogenesis 20: 1761-1767, 1999.
170. Kwak HS, Yim HS, Chock PB, and Yim MB. Endogenous intracellular glutathionyl radicals are generated in neuroblastoma cells under hydrogen peroxide oxidative stress. Proc Natl Acad Sci USA 92: 4582-4586, 1995.
171. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, and Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40: 511-515, 2002.
172. Lee K, Ozanne SE, Hales CN, and Ashford ML. Effects of chemical modification of amino and sulfhydryl groups on KATP channel function and sulfonylurea binding in CRI-G1 insulin-secreting cells. J Membr Biol 139: 167-181, 1994.
173. Lee RT and Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 17: 1859-1867, 1997.
174. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
175. Leist M, Volbracht C, Fava E, and Nicotera P. 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. Mol Pharmacol 54: 789-801, 1998.
176. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, and Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 279: 47961-47967, 2004.
177. Lesnefsky EJ and Hoppel CL. Ischemia-reperfusion injury in the aged heart: role of mitochondria. Arch Biochem Biophys 420: 287-297, 2003.
178. Li J, Huang FL, and Huang KP. Glutathiolation of proteins by glutathione disulfide S-oxide derived from S-nitrosoglutathione. Modifications of rat brain neurogranin/RC3 and neuromodulin/GAP-43. J Biol Chem 276: 3098-3105, 2001.
179. Li X, Xu Z, Li S, and Rozanski GJ. Redox regulation of Ito remodeling in diabetic rat heart. Am J Physiol Heart Circ Physiol 288: H1417-H1424, 2005.
180. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, Hakem R, Ohashi PS, and Woo M. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 25: 3620-3629, 2005.
181. Lillig CH, Berndt C, Vergnolle O, Lonn ME, Hudemann C, Bill E, and Holmgren A. Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor. Proc Natl Acad Sci U S A 102: 8168-8173, 2005.
182. Lillig CH and Holmgren A. Thioredoxin and related molecules - from biology to health and disease. Antioxid Redox Signal 9: 25-47, 2007.
183. Lillig CH, Lonn ME, Enoksson M, Fernandes AP, and Holmgren A. Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc Natl Acad Sci USA 101: 13227-13232, 2004.
184. Lin MT and Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795, 2006.
185. Lind C, Gerdes R, Schuppe-Koistinen I, and Cotgreave IA. Studies on the mechanism of oxidative modification of human glyceraldehyde-3-phosphate dehydrogenase by glutathione: catalysis by glutaredoxin. Biochem Biophys Res Commun 247: 481-486, 1998.
186. Lonn ME, Hudemann C, Berndt C, Cherkasov V, Capani F, Holmgren A, and Lillig CH. Expression pattern of human glutaredoxin 2 isoforms: identification and characterization of two testis/cancer cell-specific isoforms. Antioxid Redox Signal 10: 547-557, 2008.
187. Lou YW, Chen YY, Hsu SF, Chen RK, Lee CL, Khoo KH, Tonks NK, and Meng TC. Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells. FEBS J 275: 69-88, 2008.
188. Lundberg M, Johansson C, Chandra J, Enoksson M, Jacobsson G, Ljung J, Johansson M, and Holmgren A. Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem 276: 26269-26275, 2001.
189. Lysell J, Stjernholm VY, Ciarlo N, Holmgren A, and Sahlin L. Immunohistochemical determination of thioredoxin and glutaredoxin distribution in the human cervix, and possible relation to cervical ripening. Gynecol Endocrinol 17: 303-310, 2003.
190. Mackay HJ and Twelves CJ. Targeting the protein kinase C family: are we there yet? Nat Rev Cancer 7: 554-562, 2007.
191. Maguire-Zeiss KA, Short DW, and Federoff HJ. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain Res Mol Brain Res 134: 18-23, 2005.
192. Major CD and Wolf BA. Interleukin-1beta stimulation of c-Jun NH(2)-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction. Diabetes 50: 2721-2728, 2001.
193. Malik G, Nagy N, Ho YS, Maulik N, and Das DK. Role of glutaredoxin-1 in cardioprotection: an insight with Glrx1 transgenic and knockout animals. J Mol Cell Cardiol 44: 261-269, 2008.
194. Mallis RJ, Buss JE, and Thomas JA. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem J 355: 145-153, 2001.
195. Mancuso M, Coppede F, Migliore L, Siciliano G, and Murri L. Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis 10: 59-73, 2006.
196. Manevich Y, Feinstein SI, and Fisher AB. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci USA 101: 3780-3785, 2004.
197. Mannick JB and Schonhoff CM. Nitrosylation: the next phosphorylation? Arch Biochem Biophys 408: 1-6, 2002.
198. Maples KR, Kennedy CH, Jordan SJ, and Mason RP. In vivo thiyl free radical formation from hemoglobin following administration of hydroperoxides. Arch Biochem Biophys 277: 402-409, 1990.
199. Marfella R, Cacciapuoti F, Grassia A, Manfredi E, De Maio G, Caruso G, Pepe M, Nittolo G, and Cacciapuoti F. Role of the ubiquitin-proteasome system in carotid plaque instability in diabetic patients. Acta Cardiol 61: 630-636, 2006.
200. Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, and Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 178: 179-185, 1996.
201. Matsuo M, Tucker SJ, Ashcroft FM, Amachi T, and Ueda K. NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1. FEBS Lett 458: 292-294, 1999.
202. Mattson MP. Calcium and neurodegeneration. Aging Cell 6: 337-350, 2007.
203. Maulik N, Engelman RM, Rousou JA, Flack JE, III, Deaton D, and Das DK. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 100: II369-II375, 1999.
204. Maulik N, Sato M, Price BD, and Das DK. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 429: 365-369, 1998.
205. Mazzola JL and Sirover MA. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J Neurochem 76: 442-449, 2001.
206. McIlwain CC, Townsend DM, and Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25: 1639-1648, 2006.
207. Meyer DJ, Kramer H, Ozer N, Coles B, and Ketterer B. Kinetics and equilibria of S-nitrosothiol-thiol exchange between glutathione, cysteine, penicillamines and serum albumin. FEBS Lett 345: 177-180, 1994.
208. Mieyal JJ, Srinivasan U, Starke DW, Gravina SA, and Mieyal P.A. Glutathionyl Specificity of the Thioltransferases: Mechanistic and Physiological Implications. In: Biothiols in Health and Disease, Packer L and Cadenas E, eds. Marcel Dekker, Inc., 1995, p. 305-372.
209. Mieyal JJ, Starke DW, Gravina SA, Dothey C, and Chung JS. Thioltransferase in human red blood cells: purification and properties. Biochemistry 30: 6088-6097, 1991.
210. Mieyal JJ, Starke DW, Gravina SA, and Hocevar BA. Thioltransferase in human red blood cells: kinetics and equilibrium. Biochemistry 30: 8883-8891, 1991.
211. Mogi M, Kondo T, Mizuno Y, and Nagatsu T. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci Lett 414: 94-97, 2007.
212. Mohr S, Hallak H, de Boitte A, Lapetina EG, and Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 274: 9427-9430, 1999.
213. Mohr S, Xi X, Tang J, and Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51: 1172-1179, 2002.
214. Mossman BT, Lounsbury KM, and Reddy SP. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol 34: 666-669, 2006.
215. Mukherjee S, Gangopadhyay H, and Das DK. Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J Agric Food Chem 56: 609-617, 2008.
216. Mullonkal CJ and Toledo-Pereyra LH. Akt in ischemia and reperfusion. J Invest Surg 20: 195-203, 2007.
217. Munoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, and Labandeira-Garcia JL. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology 51: 112-120, 2006.
218. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278: 50226-50233, 2003.
219. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
220. Muscat JE, Kleinman W, Colosimo S, Muir A, Lazarus P, Park J, and Richie JP, Jr. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radic Biol Med 36: 464-470, 2004.
221. Na HK and Surh YJ. Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. Mol Carcinog 45: 368-380, 2006.
222. Nagy N, Malik G, Tosaki A, Ho YS, Maulik N, and Das DK. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J Mol Cell Cardiol 44: 252-260, 2008.
223. Nakai J, Ogura T, Protasi F, Franzini-Armstrong C, Allen PD, and Beam KG. Functional nonequality of the cardiac and skeletal ryanodine receptors. Proc Natl Acad Sci USA 94: 1019-1022, 1997.
224. Nakajima H, Amano W, Fujita A, Fukuhara A, Azuma YT, Hata F, Inui T, and Takeuchi T. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J Biol Chem 282: 26562-26574, 2007.
225. Newman SF, Sultana R, Perluigi M, Coccia R, Cai J, Pierce WM, Klein JB, Turner DM, and Butterfield DA. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res 85: 1506-1514, 2007.
226. Nonaka K, Kume N, Urata Y, Seto S, Kohno T, Honda S, Ikeda S, Muroya T, Ikeda Y, Ihara Y, Kita T, and Kondo T. Serum levels of S-glutathionylated proteins as a riskmarker for arteriosclerosis obliterans. Circ J 71: 100-105, 2007.
227. Norenberg MD and Rao KV. The mitochondrial permeability transition in neurologic disease. Neurochem Int 50: 983-997, 2007.
228. Nulton-Persson AC, Starke DW, Mieyal JJ, and Szweda LI. Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry 42: 4235-4242, 2003.
229. O'Brian CA, Liskamp RM, Solomon DH, and Weinstein IB. Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985.
230. Obin M, Shang F, Gong X, Handelman G, Blumberg J, and Taylor A. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J 12: 561-569, 1998.
231. Oikonomakos NG. Glycogen phosphorylase as a molecular target for type 2 diabetes therapy. Curr Protein Pept Sci 3: 561-586, 2002.
232. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, and Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276: 29596-29602, 2001.
233. Okuda M, Inoue N, Azumi H, Seno T, Sumi Y, Hirata K, Kawashima S, Hayashi Y, Itoh H, Yodoi J, and Yokoyama M. Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21: 1483-1487, 2001.
234. Olanow CW and Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123-144, 1999.
235. Ostrowski MC and Kistler WS. Properties of a flavoprotein sulfhydryl oxidase from rat seminal vesicle secretion. Biochemistry 19: 2639-2645, 1980.
236. Ouyang M and Shen X. Critical role of ASK1 in the 6-hydroxydopamine- induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 97: 234-244, 2006.
237. Packer L, Kraemer K, and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17: 888-895, 2001.
238. Pai HV, Starke DW, Lesnefsky EJ, Hoppel CL, and Mieyal JJ. What is the functional significance of the unique location of glutaredoxin 1 (Grx1) in the intermembrane space of mitochondria? Antioxid Redox Signal 9: 2027-2033, 2007.
239. Pan S and Berk BC. Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ Res 100: 213-219, 2007.
240. Park JB and Levine M. The human glutaredoxin gene: determination of its organization, transcription start point, and promoter analysis. Gene 197: 189-193, 1997.
241. Park JW. Reaction of S-nitrosoglutathione with sulfhydryl groups in protein. Biochem Biophys Res Commun 152: 916-920, 1988.
242. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, and Piemonte F. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem 278: 42588-42595, 2003.
243. Pei Z, Liu G, Lubben TH, and Szczepankiewicz BG. Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity. Curr Pharm Des 10: 3481-3504, 2004.
244. Peltoniemi M, Kaarteenaho-Wiik R, Saily M, Sormunen R, Paakko P, Holmgren A, Soini Y, and Kinnula VL. Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Hum Pathol 35: 1000-1007, 2004.
245. Peltoniemi MJ, Rytila PH, Harju TH, Soini YM, Salmenkivi KM, Ruddock LW, and Kinnula VL. Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respir Res 7: 133, 2006.
246. Peltoniemi MJ, Karala AR, Jurvansuu JK, Kinnula VL, and Ruddock LW. Insights into deglutathionylation reactions. Different intermediates in the glutaredoxin and protein disulfide isomerase catalyzed reactions are defined by the gamma-linkage present in glutathione. J Biol Chem 281: 33107-33114, 2006.
247. Percival MD, Ouellet M, Campagnolo C, Claveau D, and Li C. Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry 38: 13574-13583, 1999.
248. Pickel VM, Joh TH, Field PM, Becker CG, and Reis DJ. Cellular localization of tyrosine hydroxylase by immunohistochemistry. J Histochem Cytochem 23: 1-12, 1975.
249. Piemonte F, Pastore A, Tozzi G, Tagliacozzi D, Santorelli FM, Carrozzo R, Casali C, Damiano M, Federici G, and Bertini E. Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest 31: 1007-1011, 2001.
250. Pimentel DR, Adachi T, Ido Y, Heibeck T, Jiang B, Lee Y, Melendez JA, Cohen RA, and Colucci WS. Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol 41: 613-622, 2006.
251. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia dL, Perez-Sala D, and Lamas S. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 40: 14134-14142, 2001.
252. Pintus G, Tadolini B, Posadino AM, Sanna B, Debidda M, Carru C, Deiana L, and Ventura C. PKC/Raf/MEK/ERK signaling pathway modulates native-LDL-induced E2F-1 gene expression and endothelial cell proliferation. Cardiovasc Res 59: 934-944, 2003.
253. Poole LB, Karplus PA, and Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44: 325-347, 2004.
254. Popovich BK, Sayen MR and Dillmann WH. Insulin responsiveness of CK-M and CK-B mRNA in the diabetic rat heart. Am J Physiol 261: E377-E381, 1991.
255. Prestera T, Zhang Y, Spencer SR, Wilczak CA, and Talalay P. The electrophile counterattack response: protection against neoplasia and toxicity. Adv Enzyme Regul 33: 281-296, 1993.
256. Prinarakis E, Chantzoura E, Thanos D, and Spyrou G. S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFNbeta pathway. EMBO J 60: 254-257, 2008.
257. Qanungo S, Starke DW, Pai HV, Mieyal JJ, and Nieminen AL. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem 282: 18427-18436, 2007.
258. Qanungo S, Wang M, and Nieminen AL. N-Acetyl-L-cysteine enhances apoptosis through inhibition of nuclear factor-kappaB in hypoxic murine embryonic fibroblasts. J Biol Chem 279: 50455-50464, 2004.
259. Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, and Christakos S. Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 142: 3649-3655, 2001.
260. RACKER E. Glutathione-homocystine transhydrogenase. J Biol Chem 217: 867-874, 1955.
261. Rahman I. Antioxidant therapies in COPD. Int J Chron Obstruct Pulmon Dis 1: 15-29, 2006.
262. Rainwater R, Parks D, Anderson ME, Tegtmeyer P, and Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 15: 3892-3903, 1995.
263. Rao RK and Clayton LW. Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. Biochem Biophys Res Commun 293: 610-616, 2002.
264. Reddy PH. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid Redox Signal 9: 1647-1658, 2007.
265. Reddy S, Jones AD, Cross CE, Wong PS, and van der Vliet A. Inactivation of creatine kinase by S-glutathionylation of the active-site cysteine residue. Biochem J 347: 821-827, 2000.
266. Reed JA and Albino AP. Update of diagnostic and prognostic markers in cutaneous malignant melanoma. Dermatol Clin 17: 631-643, 1999.
267. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, and Janssen-Heininger YM. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 103: 13086-13091, 2006.
268. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.
269. Riedl MA and Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 8: 49-56, 2008.
270. Riedlerer PF. Views on neurodegeneration as a basis for neuroprotective strategies. Med Sci Monit 10: RA287-RA290, 2004.
271. Rohl M, Pasparakis M, Baudler S, Baumgartl J, Gautam D, Huth M, De LR, Krone W, Rajewsky K, and Bruning JC. Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest 113: 474-481, 2004.
272. Romeo G, Liu WH, Asnaghi V, Kern TS, and Lorenzi M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51: 2241-2248, 2002.
273. Rosen CF, Poon R, and Drucker DJ. UVB radiation-activated genes induced by transcriptional and posttranscriptional mechanisms in rat keratinocytes. Am J Physiol 268: C846-C855, 1995.
274. Rozell B, Barcena JA, Martinez-Galisteo E, Padilla CA, and Holmgren A. Immunochemical characterization and tissue distribution of glutaredoxin (thioltransferase) from calf. Eur J Cell Biol 62: 314-323, 1993.
275. Sahlin L, Wang H, Stjernholm Y, Lundberg M, Ekman G, Holmgren A, and Eriksson H. The expression of glutaredoxin is increased in the human cervix in term pregnancy and immediately post-partum, particularly after prostaglandin-induced delivery. Mol Hum Reprod 6: 1147-1153, 2000.
276. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
277. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423: 769-773, 2003.
278. Sampathkumar R, Balasubramanyam M, Sudarslal S, Rema M, Mohan V, and Balaram P. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin Biochem 38: 892-899, 2005.
279. Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S, Fukushima T, Ogai A, Shinozaki Y, Fujita M, Hirata A, Okuda H, Shimokawa H, Tomoike H, Hori M, and Kitakaze M. Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 110: 51-57, 2004.
280. Sanchez G, Escobar M, Pedrozo Z, Macho P, Domenech R, Hartel S, Hidalgo C, and Donoso P. Exercise and tachycardia increase NADPH oxidase and ryanodine receptor-2 activity: possible role in cardioprotection. Cardiovasc Res 77: 380-386, 2008.
281. Sanchez G, Pedrozo Z, Domenech RJ, Hidalgo C, and Donoso P. Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle. J Mol Cell Cardiol 39: 982-991, 2005.
282. Sandler AB. Molecular targeted agents in non-small-cell lung cancer. Clin Lung Cancer 5 Suppl 1: S22-S28, 2003.
283. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Grone HJ, Nelson PJ, Schlondorff D, Cohen CD, and Kretzler M. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003, 2006.
284. Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, and Ungefroren H. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondriamediated apoptosis. Int J Cancer 109: 182-1-88, 2004.
285. Schoneich C. Kinetics of thiol reactions. Methods Enzymol 251: 45-55, 1995.
286. Senatorov VV, Charles V, Reddy PH, Tagle DA, and Chuang DM. Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease. Mol Cell Neurosci 22: 285-297, 2003.
287. Shackelford RE, Heinloth AN, Heard SC, and Paules RS. Cellular and molecular targets of protein S-glutathiolation. Antioxid Redox Signal 7: 940-950, 2005.
288. Sheehan D. Detection of redox-based modification in two-dimensional electrophoresis proteomic separations. Biochem Biophys Res Commun 349: 455-462, 2006.
289. Shelton MD, Chock PB, and Mieyal JJ. Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 7: 348-366, 2005.
290. Shelton MD, Kern TS, and Mieyal JJ. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy. J Biol Chem 282: 12467-12474, 2007.
291. Shi Q, Xu H, Kleinman WA, and Gibson GE. Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochim Biophys Acta 1782: 229-238, 2008.
292. Shoelson SE, Lee J, and Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27 Suppl 3: S49-S52, 2003.
293. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, and Marsden CD. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36: 348-355, 1994.
294. Singh SP, Wishnok JS, Keshive M, Deen WM, and Tannenbaum SR. The chemistry of the S-nitrosoglutathione/ glutathione system. Proc Natl Acad Sci USA 93: 14428-14433, 1996.
295. Smith MA, Nunomura A, Zhu X, Takeda A, and Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal 2: 413-420, 2000.
296. Sohn J and Rudolph J. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry 42: 10060-10070, 2003.
297. Song JJ and Lee YJ. Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J 373: 845-853, 2003.
298. Song JJ, Rhee JG, Suntharalingam M, Walsh SA, Spitz DR, and Lee YJ. Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2. J Biol Chem 277: 46566-46575, 2002.
299. Song P, Wu Y, Xu J, Xie Z, Dong Y, Zhang M, and Zou MH. Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner. Circulation 116: 1585-1595, 2007.
300. Srinivasan U, Mieyal PA, and Mieyal JJ. pH profiles indicative of rate-limiting nucleophilic displacement in thioltransferase catalysis. Biochemistry 36: 3199-3206, 1997.
301. Srivastava SK, Ramana KV, and Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26: 380-392, 2005.
302. Stamler JS, Singel DJ, and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
303. Starke DW, Chock PB, and Mieyal JJ. Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction. J Biol Chem 278: 14607-14613, 2003.
304. Stavreus-Evers A, Masironi B, Landgren BM, Holmgren A, Eriksson H, and Sahlin L. Immunohistochemical localization of glutaredoxin and thioredoxin in human endometrium: a possible association with pinopodes. Mol Hum Reprod 8: 546-551, 2002.
305. Strosznajder RP, Jesko H, Banasik M, and Tanaka S. Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress. J Physiol Pharmacol 56: 215-221, 2005.
306. Sullivan DM, Wehr NB, Fergusson MM, Levine RL, and Finkel T. Identification of oxidant-sensitive proteins: TNF-alpha induces protein glutathiolation. Biochemistry 39: 11121-11128, 2000.
307. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
308. Swift LL. Role of the Golgi apparatus in the phosphorylation of apolipoprotein B. J Biol Chem 271: 31491-31495, 1996.
309. Tao L and English AM. Protein S-glutathiolation triggered by decomposed S-nitrosoglutathione. Biochemistry 43: 4028-4038, 2004.
310. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, and Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278: 19603-19610, 2003.
311. Terada LS. Specificity in reactive oxidant signaling: think globally, act locally. J Cell Biol 174: 615-623, 2006.
312. Tew KD. Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem Pharmacol 73: 1257-1269, 2007.
313. Thomas JA, Poland B, and Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys 319: 1-9, 1995.
314. Thorpe C, Hoober KL, Raje S, Glynn NM, Burnside J, Turi GK, and Coppock DL. Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes. Arch Biochem Biophys 405: 1-12, 2002.
315. Tomlinson DR and Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci 9: 36-45, 2008.
316. Tong X, Ying J, Pimentel DR, Trucillo M, Adachi T, and Cohen RA. High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration. J Mol Cell Cardiol 44: 361-369, 2008.
317. Tonks NK. PTP1B: from the sidelines to the front lines! FEBS Lett 546: 140-148, 2003.
318. Townsend DM. S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7: 313-324, 2007.
319. Townsend DM, Findlay VJ, Fazilev F, Ogle M, Fraser J, Saavedra JE, Ji X, Keefer LK, and Tew KD. A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Mol Pharmacol 69: 501-508, 2006.
320. Townsend DM, Findlay VL, and Tew KD. Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol 401: 287-307, 2005.
321. Trapp S, Proks P, Tucker SJ, and Ashcroft FM. Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP. J Gen Physiol 112: 333-349, 1998.
322. Trapp S, Tucker SJ, and Ashcroft FM. Mechanism of ATP-sensitive K channel inhibition by sulfhydryl modification. J Gen Physiol 112: 325-332, 1998.
323. Treadway JL, Mendys P, and Hoover DJ. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opin Investig Drugs 10: 439-454, 2001.
324. Tretter L, Sipos I, and Adam-Vizi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem Res 29: 569-577, 2004.
325. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S, and Kondo T. 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem 281: 13092-13102, 2006.
326. van den Berghe N, Ouwens DM, Maassen JA, van Mackelenbergh MG, Sips HC, and Krans HM. Activation of the Ras/mitogen-activated protein kinase signaling pathway alone is not sufficient to induce glucose uptake in 3T3-L1 adipocytes. Mol Cell Biol 14: 2372-2377, 1994.
327. van Montfort RL, Congreve M, Tisi D, Carr R, and Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423: 773-777, 2003.
328. Velu CS, Niture SK, Doneanu CE, Pattabiraman N ,and Srivenugopal KS. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46: 7765-7780, 2007.
329. Viner RI, Williams TD, and Schoneich C. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 38: 12408-12415, 1999.
330. Vojtek AB and Der CJ. Increasing complexity of the Ras signaling pathway. J Biol Chem 273: 19925-19928, 1998.
331. Walters DM, Cho HY, and Kleeberger SR. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxid Redox Signal 10: 321-332, 2008.
332. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, and Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88: 947-953, 2001.
333. Wang J, Boja ES, Tan W, Tekle E, Fales HM, English S, Mieyal JJ, and Chock PB. Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276: 47763-47766, 2001.
334. Wang J, Pan S, and Berk BC. Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner. Arterioscler Thromb Vasc Biol 27: 1283-1288, 2007.
335. Wang J, Tekle E, Oubrahim H, Mieyal JJ, Stadtman ER, and Chock PB. Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci USA 100: 5103-5106, 2003.
336. Wang T, Arifoglu P, Ronai Z, and Tew KD. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276: 20999-21003, 2001.
337. Wang Y, Qiao M, Mieyal JJ, Asmis LM, and Asmis R. Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: role of glutathione reductase and glutaredoxin. Free Radic Biol Med 41: 775-785, 2006.
338. Ward NE, Stewart JR, Ioannides CG, and O'Brian CA. Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Biochemistry 39: 10319-10329, 2000.
339. Wardman P and von Sonntag C. Kinetic factors that control the fate of thiyl radicals in cells. Methods Enzymol 251: 31-45, 1995.
340. Weik R and Neumcke B. ATP-sensitive potassium channels in adult mouse skeletal muscle: characterization of the ATP-binding site. J Membr Biol 110: 217-226, 1989.
341. Wells WW, Rocque PA, Xu DP, Meyer EB, Charamella LJ, and Dimitrov NV. Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells. Free Radic Biol Med 18: 699-708, 1995.
342. West MB, Hill BG, Xuan YT, and Bhatnagar A. Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification. FASEB J 20: 1715-1717, 2006.
343. Wheldrake JF and Pasternak CA. The oxidation of cyst(e)ine by mast-cell tumour P815 in culture. Biochem J 106: 437-444, 1968.
344. Winterbourn CC and Metodiewa D. Reaction of superoxide with glutathione and other thiols. Methods Enzymol 251: 81-86, 1995.
345. Yang Y, Jao S, Nanduri S, Starke DW, Mieyal JJ, and Qin J. Reactivity of the human thioltransferase (glutaredoxin) C7S, C25S, C78S, C82S mutant and NMR solution structure of its glutathionyl mixed disulfide intermediate reflect catalytic specificity. Biochemistry 37: 17145-17156, 1998.
346. Yaras N, Ugur M, Ozdemir S, Gurdal H, Purali N, Lacampagne A, Vassort G, and Turan B. Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes 54: 3082-3088, 2005.
347. Yates MS and Kensler TW. Chemopreventive promise of targeting the Nrf2 pathway. Drug News Perspect 20: 109-117, 2007.
348. Yoneda K, Chang MM, Chmiel K, Chen Y, and Wu R. Application of high-density DNA microarray to study smokeand hydrogen peroxide-induced injury and repair in human bronchial epithelial cells. J Am Soc Nephrol 14: S284-S289, 2003.
349. Yoshitake S, Nanri H, Fernando MR, and Minakami S. Possible differences in the regenerative roles played by thioltransferase and thioredoxin for oxidatively damaged proteins. J Biochem (Tokyo) 116: 42-46, 1994.
350. Zdychova J, Vesela J, Kazdova L, and Komers R. Renal activity of Akt kinase in experimental Type 1 diabetes. Physiol Res 2007 [epub Oct. 11, 2007].
351. Zhang ZY and Lee SY. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin Investig Drugs 12: 223-233, 2003.
352. Zheng L, Szabo C, and Kern TS. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53: 2960-2967, 2004.